{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:46Z","timestamp":1786982206246,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02719-z","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:56:09Z","timestamp":1745247369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Up-regulation of thrombospondin-1 inhibits the progression of gallbladder cancer"],"prefix":"10.1007","volume":"42","author":[{"given":"Chang","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"2719_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garcia P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022;8:69.","journal-title":"Nat Rev Dis Primers"},{"key":"2719_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106234","volume":"98","author":"CF Feo","year":"2022","unstructured":"Feo CF, Ginesu GC, Fancellu A, Perra T, Ninniri C, Deiana G, Scanu AM, Porcu A. Current management of incidental gallbladder cancer: a review. Int J Surg. 2022;98: 106234.","journal-title":"Int J Surg"},{"key":"2719_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21037\/cco.2019.06.06","volume":"8","author":"RW Krell","year":"2019","unstructured":"Krell RW, Wei AC. Gallbladder cancer: surgical management. Chin Clin Oncol. 2019;8:36.","journal-title":"Chin Clin Oncol"},{"key":"2719_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21037\/cco.2019.08.13","volume":"8","author":"MA Schmidt","year":"2019","unstructured":"Schmidt MA, Marcano-Bonilla L, Roberts LR. Gallbladder cancer: epidemiology and genetic risk associations. Chin Clin Oncol. 2019;8:31.","journal-title":"Chin Clin Oncol"},{"key":"2719_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-3-031-61238-1_8","volume":"192","author":"CT Marcinak","year":"2024","unstructured":"Marcinak CT, Abbott DE. Gallbladder cancer. Cancer Treat Res. 2024;192:147\u201363.","journal-title":"Cancer Treat Res"},{"key":"2719_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.soc.2019.06.005","volume":"28","author":"L Cherkassky","year":"2019","unstructured":"Cherkassky L, D\u2019Angelica M. Gallbladder cancer: managing the incidental diagnosis. Surg Oncol Clin N Am. 2019;28:619\u201330.","journal-title":"Surg Oncol Clin N Am"},{"key":"2719_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.21037\/cco.2019.08.14","volume":"8","author":"M Javle","year":"2019","unstructured":"Javle M, Zhao H, Abou-Alfa GK. Systemic therapy for gallbladder cancer. Chin Clin Oncol. 2019;8:44.","journal-title":"Chin Clin Oncol"},{"key":"2719_CR8","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1007\/s11033-020-05269-x","volume":"47","author":"P Baichan","year":"2020","unstructured":"Baichan P, Naicker P, Devar JWS, Smith M, Candy GP, Nweke E. Targeting gallbladder cancer: a pathway based perspective. Mol Biol Rep. 2020;47:2361\u20139.","journal-title":"Mol Biol Rep"},{"key":"2719_CR9","doi-asserted-by":"crossref","unstructured":"Kale A, Rogers NM, Ghimire K. Thrombospondin-1 CD47 signalling: from mechanisms to medicine. Int J Mol Sci 2021;22","DOI":"10.3390\/ijms22084062"},{"key":"2719_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114149","volume":"43","author":"D Vanhoutte","year":"2024","unstructured":"Vanhoutte D, Schips TG, Minerath RA, Huo J, Kavuri NSS, Prasad V, Lin SC, Bround MJ, Sargent MA, Adams CM, Molkentin JD. Thbs1 regulates skeletal muscle mass in a TGFbeta-Smad2\/3-ATF4-dependent manner. Cell Rep. 2024;43: 114149.","journal-title":"Cell Rep"},{"key":"2719_CR11","first-page":"291","volume":"24","author":"JS Isenberg","year":"2020","unstructured":"Isenberg JS, Roberts DD. THBS1 (thrombospondin-1). Atlas Genet Cytogenet Oncol Haematol. 2020;24:291\u20139.","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"2719_CR12","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/j.1349-7006.2007.00534.x","volume":"98","author":"M Yamauchi","year":"2007","unstructured":"Yamauchi M, Imajoh-Ohmi S, Shibuya M. Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle. Cancer Sci. 2007;98:1491\u20137.","journal-title":"Cancer Sci"},{"key":"2719_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.664696","volume":"9","author":"V Morandi","year":"2021","unstructured":"Morandi V, Petrik J, Lawler J. Endothelial cell behavior is determined by receptor clustering induced by thrombospondin-1. Front Cell Dev Biol. 2021;9: 664696.","journal-title":"Front Cell Dev Biol"},{"key":"2719_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4103\/0019-509X.200658","volume":"53","author":"PS Roy","year":"2016","unstructured":"Roy PS, Saikia BJ. Cancer and cure: a critical analysis. Indian J Cancer. 2016;53:441\u20132.","journal-title":"Indian J Cancer"},{"key":"2719_CR15","doi-asserted-by":"publisher","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","volume":"50","author":"R Kaur","year":"2023","unstructured":"Kaur R, Bhardwaj A, Gupta S. Cancer treatment therapies: traditional to modern approaches to combat cancers. Mol Biol Rep. 2023;50:9663\u201376.","journal-title":"Mol Biol Rep"},{"key":"2719_CR16","first-page":"3855","volume":"22","author":"JJ Wang","year":"2018","unstructured":"Wang JJ, Lei KF, Han F. Tumor microenvironment: recent advances in various cancer treatments. Eur Rev Med Pharmacol Sci. 2018;22:3855\u201364.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2719_CR17","doi-asserted-by":"publisher","first-page":"5825401","DOI":"10.1155\/2020\/5825401","volume":"2020","author":"Y Igarashi","year":"2020","unstructured":"Igarashi Y, Sasada T. Cancer vaccines: toward the next breakthrough in cancer immunotherapy. J Immunol Res. 2020;2020:5825401.","journal-title":"J Immunol Res"},{"key":"2719_CR18","doi-asserted-by":"crossref","unstructured":"de Castro Sant' Anna C, Junior AGF, Soares P, Tuji F, Paschoal E, Chaves LC, Burbano RR. Molecular biology as a tool for the treatment of cancer. Clin Exp Med. 2018;18:457\u201364","DOI":"10.1007\/s10238-018-0518-1"},{"key":"2719_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-319-77736-8_10","volume":"1063","author":"K Nabi","year":"2018","unstructured":"Nabi K, Le A. The intratumoral heterogeneity of cancer metabolism. Adv Exp Med Biol. 2018;1063:131\u201345.","journal-title":"Adv Exp Med Biol"},{"key":"2719_CR20","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","volume":"187","author":"A Passaro","year":"2024","unstructured":"Passaro A, Al Bakir M, Hamilton EG, Diehn M, Andre F, Roy-Chowdhuri S, Mountzios G, Wistuba II, Swanton C, Peters S. Cancer biomarkers: emerging trends and clinical implications for personalized treatment. Cell. 2024;187:1617\u201335.","journal-title":"Cell"},{"key":"2719_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113773","volume":"43","author":"J Giraud","year":"2024","unstructured":"Giraud J, Chalopin D, Ramel E, Boyer T, Zouine A, Derieppe MA, Larmonier N, Adotevi O, Le Bail B, Blanc JF, Laurent C, Chiche L, Derive M, Nikolski M, Saleh M. THBS1(+) myeloid cells expand in SLD hepatocellular carcinoma and contribute to immunosuppression and unfavorable prognosis through TREM1. Cell Rep. 2024;43: 113773.","journal-title":"Cell Rep"},{"key":"2719_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.gene.2015.10.004","volume":"576","author":"TD Singh","year":"2016","unstructured":"Singh TD, Gupta S, Shrivastav BR, Tiwari PK. Epigenetic profiling of gallbladder cancer and gall stone diseases: evaluation of role of tumour associated genes. Gene. 2016;576:743\u201352.","journal-title":"Gene"},{"key":"2719_CR23","doi-asserted-by":"publisher","first-page":"1027914","DOI":"10.3389\/fonc.2022.1027914","volume":"12","author":"R Priya","year":"2022","unstructured":"Priya R, Jain V, Akhtar J, Saklani N, Sakhuja P, Agarwal AK, Polisetty RV, Sirdeshmukh R, Kar S, Gautam P. Proteomic profiling of cell line-derived extracellular vesicles to identify candidate circulatory markers for detection of gallbladder cancer. Front Oncol. 2022;12:1027914.","journal-title":"Front Oncol"},{"key":"2719_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.suc.2014.01.009","volume":"94","author":"JA Wernberg","year":"2014","unstructured":"Wernberg JA, Lucarelli DD. Gallbladder cancer. Surg Clin North Am. 2014;94:343\u201360.","journal-title":"Surg Clin North Am"},{"key":"2719_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2021.101130","volume":"67","author":"R Lam","year":"2021","unstructured":"Lam R, Zakko A, Petrov JC, Kumar P, Duffy AJ, Muniraj T. Gallbladder disorders: a comprehensive review. Dis Mon. 2021;67: 101130.","journal-title":"Dis Mon"},{"key":"2719_CR26","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.3748\/wjg.v26.i22.2967","volume":"26","author":"MH Yu","year":"2020","unstructured":"Yu MH, Kim YJ, Park HS, Jung SI. Benign gallbladder diseases: Imaging techniques and tips for differentiating with malignant gallbladder diseases. World J Gastroenterol. 2020;26:2967\u201386.","journal-title":"World J Gastroenterol"},{"key":"2719_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/0846537120923273","volume":"71","author":"S John","year":"2020","unstructured":"John S, Moyana T, Shabana W, Walsh C, McInnes MDF. Gallbladder cancer: imaging appearance and pitfalls in diagnosis [Formula: see text]. Can Assoc Radiol J. 2020;71:448\u201358.","journal-title":"Can Assoc Radiol J"},{"key":"2719_CR28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.trecan.2020.03.003","volume":"6","author":"PK Tiwari","year":"2020","unstructured":"Tiwari PK. Epigenetic biomarkers in gallbladder cancer. Trends Cancer. 2020;6:540\u20133.","journal-title":"Trends Cancer"},{"key":"2719_CR29","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.suc.2024.03.006","volume":"104","author":"GC Waller","year":"2024","unstructured":"Waller GC, Sarpel U. Gallbladder cancer. Surg Clin North Am. 2024;104:1263\u201380.","journal-title":"Surg Clin North Am"},{"key":"2719_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jss.2020.08.041","volume":"258","author":"FB Maegawa","year":"2021","unstructured":"Maegawa FB, Ashouri Y, Hamidi M, Hsu CH, Riall TS. Gallbladder cancer surgery in the United States: lymphadenectomy trends and impact on survival. J Surg Res. 2021;258:54\u201363.","journal-title":"J Surg Res"},{"key":"2719_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.bbapap.2014.10.014","volume":"1854","author":"M Masuda","year":"2015","unstructured":"Masuda M, Yamada T. Signaling pathway profiling by reverse-phase protein array for personalized cancer medicine. Biochim Biophys Acta. 2015;1854:651\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"2719_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1586\/14737159.5.3.315","volume":"5","author":"AA Ewis","year":"2005","unstructured":"Ewis AA, Zhelev Z, Bakalova R, Fukuoka S, Shinohara Y, Ishikawa M, Baba Y. A history of microarrays in biomedicine. Expert Rev Mol Diagn. 2005;5:315\u201328.","journal-title":"Expert Rev Mol Diagn"},{"key":"2719_CR33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458:719\u201324.","journal-title":"Nature"},{"key":"2719_CR34","first-page":"838","volume":"22","author":"Z Tao","year":"2017","unstructured":"Tao Z, Shi A, Li R, Wang Y, Wang X, Zhao J. Microarray bioinformatics in cancer- a review. J Buon. 2017;22:838\u201343.","journal-title":"J BUON"},{"key":"2719_CR35","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41576-021-00338-8","volume":"22","author":"D Chakravarty","year":"2021","unstructured":"Chakravarty D, Solit DB. Clinical cancer genomic profiling. Nat Rev Genet. 2021;22:483\u2013501.","journal-title":"Nat Rev Genet"},{"key":"2719_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2020.121436","volume":"220","author":"HK Kordasht","year":"2020","unstructured":"Kordasht HK, Hasanzadeh M. Aptamer based recognition of cancer cells: Recent progress and challenges in bioanalysis. Talanta. 2020;220: 121436.","journal-title":"Talanta"},{"key":"2719_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-3-319-47656-8_9","volume":"965","author":"EG Armitage","year":"2017","unstructured":"Armitage EG, Ciborowski M. Applications of metabolomics in cancer studies. Adv Exp Med Biol. 2017;965:209\u201334.","journal-title":"Adv Exp Med Biol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02719-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02719-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02719-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T21:59:27Z","timestamp":1746136767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02719-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["2719"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02719-z","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All studies involving human specimens obtained the written informed consent of patients, and all animal experiments followed the guidelines of the China Animal Protection Association. This study was approved by the ethics committee of Bengbu Medical College (ethical approval (2023) No. 111\/(2024)184).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"170"}}